Barclays Cuts HCA Healthcare (NYSE:HCA) Price Target to $392.00

HCA Healthcare (NYSE:HCA) had its price target lowered by equities research analysts at Barclays from $396.00 to $392.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Barclays‘s price target points to a potential upside of 10.96% from the stock’s current price.

Other equities research analysts have also recently issued research reports about the company. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Royal Bank of Canada raised their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. Oppenheimer upped their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. UBS Group raised their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Finally, Morgan Stanley assumed coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target for the company. Five analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $379.17.

HCA Healthcare Stock Performance

Shares of HCA traded down $2.76 during midday trading on Friday, hitting $353.27. 642,597 shares of the stock traded hands, compared to its average volume of 1,176,349. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. HCA Healthcare has a 1-year low of $226.48 and a 1-year high of $417.14. The business’s 50 day moving average price is $391.18 and its two-hundred day moving average price is $355.72. The firm has a market capitalization of $89.48 billion, a PE ratio of 15.84, a price-to-earnings-growth ratio of 1.39 and a beta of 1.68.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.70% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. Prospera Private Wealth LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $133,000. PNC Financial Services Group Inc. grew its stake in HCA Healthcare by 1.7% in the third quarter. PNC Financial Services Group Inc. now owns 39,433 shares of the company’s stock valued at $16,027,000 after acquiring an additional 654 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in shares of HCA Healthcare during the third quarter worth $5,084,000. Banque Cantonale Vaudoise raised its stake in shares of HCA Healthcare by 25.6% in the 3rd quarter. Banque Cantonale Vaudoise now owns 12,187 shares of the company’s stock valued at $4,953,000 after purchasing an additional 2,481 shares during the period. Finally, Prospera Financial Services Inc raised its holdings in shares of HCA Healthcare by 204.2% in the third quarter. Prospera Financial Services Inc now owns 2,917 shares of the company’s stock valued at $1,186,000 after purchasing an additional 1,958 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.